{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:07:26Z","timestamp":1793945246514,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EB029752"],"award-info":[{"award-number":["R01 EB029752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023938","name":"Mallinckrodt Institute of Radiology","doi-asserted-by":"publisher","award":["Pilot Fund Program"],"award-info":[{"award-number":["Pilot Fund Program"]}],"id":[{"id":"10.13039\/100023938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023938","name":"Mallinckrodt Institute of Radiology","doi-asserted-by":"publisher","award":["Small-Animal Magnetic Resonance Facility"],"award-info":[{"award-number":["Small-Animal Magnetic Resonance Facility"]}],"id":[{"id":"10.13039\/100023938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","award":["Small-Animal Cancer Imaging Shared Resource"],"award-info":[{"award-number":["Small-Animal Cancer Imaging Shared Resource"]}],"id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objectives<\/jats:title>\n                    <jats:p>Immune checkpoint blockade (ICB) therapy has been ineffective in glioblastoma (GBM) that recurs following standard-of-care resection and chemoradiation of the primary tumor. Herein, we investigate whether the delayed effect of intracranial radiation alters the tumor lesion metabolic profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Na\u00efve (non-irradiated) GL261 tumor cells were implanted into the brains of C57BL\/6 mice. Brains of one cohort were hemispherically irradiated six weeks prior to implantation, ultimately resulting in ICB refractory GBM. Brains of the control cohort were not irradiated. Following subcutaneous infusion of [6,6-\n                      <jats:sup>2<\/jats:sup>\n                      H\n                      <jats:sub>2<\/jats:sub>\n                      ] glucose (Glc), single voxel deuterium metabolic imaging (DMI) monitored Glc uptake and the production of semi-heavy water (HOD),\n                      <jats:sup>2<\/jats:sup>\n                      H\n                      <jats:sub>2<\/jats:sub>\n                      -lactate (Lac) and the 50\/50 mix of [\n                      <jats:sup>2<\/jats:sup>\n                      H\n                      <jats:sub>2<\/jats:sub>\n                      -glutamate\u2009+\u2009\n                      <jats:sup>2<\/jats:sup>\n                      H\n                      <jats:sub>2<\/jats:sub>\n                      -glutamine] (Glx).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GL261 tumors growing in previously irradiated brain showed reduced Warburg effect (aerobic glycolysis; glucose\u2009\u2192\u2009lactate) and greater TCA cycle activity (respiration, oxidative phosphorylation) relative to tumors growing in non-irradiated brain as evidenced by cohort differences in the ratios Glx\/Lac (p\u2009&lt;\u20090.01), Glx\/Glc (p\u2009&lt;\u20090.02), and Lac\/Glc (p\u2009&lt;\u20090.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A metabolic program skewed\u00a0toward oxidative phosphorylation and away from glycolysis has been associated with immune dysfunction. This study documents such a skewed metabolic state in ICB refractory GL261 GBM growing in irradiated brain (tumors were not irradiated) compared to control brain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11307-025-02037-w","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:28:43Z","timestamp":1759505323000},"page":"870-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Shift Mirrors GBM Immunity to Anti-PD-L1 Immunotherapy: A Deuterium MRS Study"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-2703","authenticated-orcid":false,"given":"Joel R.","family":"Garbow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanner M.","family":"Johanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Engelbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J. H.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"2037_CR1","doi-asserted-by":"publisher","first-page":"693146","DOI":"10.3389\/fonc.2021.693146","volume":"11","author":"JR Garbow","year":"2021","unstructured":"Garbow JR, Johanns TM, Ge X et al (2021) Irradiation-modulated murine brain microenvironment enhances gl261-tumor growth and inhibits anti-PD-L1 immunotherapy. Front Oncol 11:693146","journal-title":"Front Oncol"},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","volume":"17","author":"SB Goldberg","year":"2016","unstructured":"Goldberg SB, Gettinger SN, Mahajan A et al (2016) Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol 17:976\u2013983","journal-title":"Lancet Oncol"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","volume":"19","author":"GV Long","year":"2018","unstructured":"Long GV, Atkinson V, Lo S et al (2018) Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol 19:672\u2013681","journal-title":"Lancet Oncol"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-018-03020-y","volume":"141","author":"VM Lu","year":"2019","unstructured":"Lu VM, Goyal A, Rovin RA, Lee A, McDonald KL (2019) Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis. J Neurooncol 141:1\u201312","journal-title":"J Neurooncol"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","volume":"24","author":"M Lim","year":"2022","unstructured":"Lim M, Weller M, Idbaih A et al (2022) Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter. Neuro Oncol 24:1935\u20131949","journal-title":"Neuro Oncol"},{"key":"2037_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/noac099","volume":"25","author":"A Omuro","year":"2023","unstructured":"Omuro A, Brandes AA, Carpentier AF et al (2023) Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial. Neuro Oncol 25:123\u2013134","journal-title":"Neuro Oncol"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","volume":"6","author":"DA Reardon","year":"2020","unstructured":"Reardon DA, Brandes AA, Omuro A et al (2020) Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 Phase 3 randomized clinical trial. JAMA Oncol 6:1003\u20131010","journal-title":"JAMA Oncol"},{"key":"2037_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.21.02508","volume":"41","author":"KJ Harrington","year":"2023","unstructured":"Harrington KJ, Burtness B, Greil R et al (2023) Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study. J Clin Oncol 41:790\u2013802","journal-title":"J Clin Oncol"},{"key":"2037_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","volume":"25","author":"JP Machiels","year":"2024","unstructured":"Machiels JP, Tao Y, Licitra L et al (2024) Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial. Lancet Oncol 25:572\u2013587","journal-title":"Lancet Oncol"},{"key":"2037_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/mrm.29888","volume":"91","author":"KH Song","year":"2024","unstructured":"Song KH, Ge X, Engelbach JA et al (2024) Subcutaneous deuterated substrate administration in mice: An alternative to tail vein infusion. Magn Reson Med 91:681\u2013686","journal-title":"Magn Reson Med"},{"key":"2037_CR11","doi-asserted-by":"publisher","first-page":"885480","DOI":"10.3389\/fonc.2022.885480","volume":"12","author":"X Ge","year":"2022","unstructured":"Ge X, Song K-H, Engelbach JA et al (2022) Distinguishing tumor admixed in a radiation necrosis (RN) Background: 1H and 2H MR with a novel mouse brain-tumor\/RN model. Front Oncol 12:885480","journal-title":"Front Oncol"},{"key":"2037_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11307-023-01837-2","volume":"26","author":"KH Song","year":"2024","unstructured":"Song KH, Ge X, Engelbach J, Rich KM, Ackerman JJH, Garbow JR (2024) Deuterium magnetic resonance spectroscopy quantifies tumor fraction in a mouse model of a mixed radiation necrosis \/ GL261-glioblastoma lesion. Mol Imaging Biol 26:173\u2013178","journal-title":"Mol Imaging Biol"},{"issue":"8","key":"2037_CR13","doi-asserted-by":"publisher","first-page":"eaat7314","DOI":"10.1126\/sciadv.aat7314","volume":"4","author":"HM De Feyter","year":"2018","unstructured":"De Feyter HM, Behar KL, Corbin ZA, Fulbright RK, Brown PB, McIntyre S, Nixon TW, Rothman DL, de Graaf RA (2018) Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Science advances. 4(8):eaat7314","journal-title":"Science advances."},{"key":"2037_CR14","doi-asserted-by":"publisher","first-page":"106932","DOI":"10.1016\/j.jmr.2021.106932","volume":"326","author":"HM De Feyter","year":"2021","unstructured":"De Feyter HM, de Graaf RA (2021) Deuterium metabolic imaging - back to the future. J Magn Reson 326:106932","journal-title":"J Magn Reson"},{"key":"2037_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.2019191242","volume":"294","author":"F Kreis","year":"2020","unstructured":"Kreis F, Wright AJ, Hesse F, Fala M, Hu DE, Brindle KM (2020) Measuring tumor glycolytic flux in vivo by using fast deuterium MRI. Radiology 294:289\u2013296","journal-title":"Radiology"},{"key":"2037_CR16","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1177\/0271678X17706444","volume":"37","author":"M Lu","year":"2017","unstructured":"Lu M, Zhu XH, Zhang Y, Mateescu G, Chen W (2017) Quantitative assessment of brain glucose metabolic rates using in vivo deuterium magnetic resonance spectroscopy. J Cereb Blood Flow Metab 37:3518\u20133530","journal-title":"J Cereb Blood Flow Metab"},{"key":"2037_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41747-024-00464-y","volume":"8","author":"F Pan","year":"2024","unstructured":"Pan F, Liu X, Wan J et al (2024) Advances and prospects in deuterium metabolic imaging (DMI): a systematic review of in vivo studies. Eur Radiol Exp 8:65","journal-title":"Eur Radiol Exp"},{"key":"2037_CR18","doi-asserted-by":"publisher","first-page":"102932","DOI":"10.1016\/j.nicl.2021.102932","volume":"33","author":"RV Simoes","year":"2022","unstructured":"Simoes RV, Henriques RN, Cardoso BM, Fernandes FF, Carvalho T, Shemesh N (2022) Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma. Neuroimage Clin 33:102932","journal-title":"Neuroimage Clin"},{"issue":"2","key":"2037_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1227\/01.NEU.0000249264.80579.37","volume":"60","author":"SC Jost","year":"2007","unstructured":"Jost SC, Wanebo JE, Song SK, Chicoine MR, Rich KM, Woolsey TA, Lewis JS, Mach RH, Xu J, Garbow JR (2007) In vivo imaging in a murine model of glioblastoma. Neurosurgery 60(2):360\u201371","journal-title":"Neurosurgery"},{"key":"2037_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/mrm.21043","volume":"56","author":"V Mlynarik","year":"2006","unstructured":"Mlynarik V, Gambarota G, Frenkel H, Gruetter R (2006) Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn Reson Med 56:965\u2013970","journal-title":"Magn Reson Med"},{"key":"2037_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1148\/radiology.164.2.3602402","volume":"164","author":"JP Felmlee","year":"1987","unstructured":"Felmlee JP, Ehman RL (1987) Spatial presaturation: a method for suppressing flow artifacts and improving depiction of vascular anatomy in MR imaging. Radiology 164:559\u2013564","journal-title":"Radiology"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"W03419","DOI":"10.1029\/2006WR005186","volume":"43","author":"GJ Bowen","year":"2007","unstructured":"Bowen GJ, Ehleringer JR, Chesson LA, Stange E, Cerling TE (2007) Stable isotope ratios of tap water in the contiguous United States. Water Resour Res 43:W03419. https:\/\/doi.org\/10.1029\/2006WR005186","journal-title":"Water Resour Res"},{"key":"2037_CR23","doi-asserted-by":"publisher","first-page":"e21467","DOI":"10.1002\/cmr.a.21467","volume":"47A","author":"JD Quirk","year":"2019","unstructured":"Quirk JD, Bretthorst GL, Garbow JR, Ackerman JJH (2019) Magnetic resonance data modeling: the bayesian analysis toolbox. Concepts Magn Reson Part A 47A:e21467","journal-title":"Concepts Magn Reson Part A"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/acschemneuro.0c00711","volume":"12","author":"RA de Graaf","year":"2021","unstructured":"de Graaf RA, Thomas MA, Behar KL, De Feyter HM (2021) Characterization of kinetic isotope effects and label loss in deuterium-based isotopic labeling studies. ACS Chem Neurosci 12:234\u2013243","journal-title":"ACS Chem Neurosci"},{"key":"2037_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0033-0620(77)90019-6","volume":"20","author":"JB Bassingthwaighte","year":"1977","unstructured":"Bassingthwaighte JB (1977) Physiology and theory of tracer washout techniques for the estimation of myocardial blood flow: flow estimation from tracer washout. Prog Cardiovasc Dis 20:165\u2013189","journal-title":"Prog Cardiovasc Dis"},{"key":"2037_CR26","first-page":"782","volume":"24","author":"P Herscovitch","year":"1983","unstructured":"Herscovitch P, Markham J, Raichle ME (1983) Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. J Nucl Med 24:782\u2013789","journal-title":"J Nucl Med"},{"key":"2037_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/jcbfm.1987.102","volume":"7","author":"P Herscovitch","year":"1987","unstructured":"Herscovitch P, Raichle ME, Kilbourn MR, Welch MJ (1987) Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab 7:527\u2013542","journal-title":"J Cereb Blood Flow Metab"},{"key":"2037_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269\u2013270","journal-title":"Science"},{"key":"2037_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519\u2013530","journal-title":"J Gen Physiol"},{"key":"2037_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nov125","volume":"18","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Zadeh G (2016) Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions. Neuro Oncol 18:160\u2013172","journal-title":"Neuro Oncol"},{"key":"2037_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/10409238.2018.1556578","volume":"53","author":"S Ganapathy-Kanniappan","year":"2018","unstructured":"Ganapathy-Kanniappan S (2018) Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype. Crit Rev Biochem Mol Biol 53:667\u2013682","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2037_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.27712","volume":"132","author":"SR Chirasani","year":"2013","unstructured":"Chirasani SR, Leukel P, Gottfried E et al (2013) Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. Int J Cancer 132:843\u2013853","journal-title":"Int J Cancer"},{"key":"2037_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","volume":"43","author":"V Huber","year":"2017","unstructured":"Huber V, Camisaschi C, Berzi A et al (2017) Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol 43:74\u201389","journal-title":"Semin Cancer Biol"},{"key":"2037_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fimmu.2016.00052","volume":"7","author":"S Romero-Garcia","year":"2016","unstructured":"Romero-Garcia S, Moreno-Altamirano MM, Prado-Garcia H, Sanchez-Garcia FJ (2016) Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front Immunol 7:52","journal-title":"Front Immunol"},{"key":"2037_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","volume":"9","author":"NM Anderson","year":"2018","unstructured":"Anderson NM, Mucka P, Kern JG, Feng H (2018) The emerging role and targetability of the TCA cycle in cancer metabolism. Protein Cell 9:216\u2013237","journal-title":"Protein Cell"},{"key":"2037_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biochi.2017.02.008","volume":"135","author":"K Sajnani","year":"2017","unstructured":"Sajnani K, Islam F, Smith RA, Gopalan V, Lam AK (2017) Genetic alterations in Krebs cycle and its impact on cancer pathogenesis. Biochimie 135:164\u2013172","journal-title":"Biochimie"},{"key":"2037_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4049\/jimmunol.0901698","volume":"185","author":"JC Rodriguez-Prados","year":"2010","unstructured":"Rodriguez-Prados JC, Traves PG, Cuenca J et al (2010) Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 185:605\u2013614","journal-title":"J Immunol"},{"key":"2037_CR38","doi-asserted-by":"publisher","first-page":"105290","DOI":"10.1016\/j.nbd.2021.105290","volume":"152","author":"S Yang","year":"2021","unstructured":"Yang S, Qin C, Hu ZW et al (2021) Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system. Neurobiol Dis 152:105290","journal-title":"Neurobiol Dis"},{"key":"2037_CR39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"EL Pearce","year":"2013","unstructured":"Pearce EL, Pearce EJ (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38:633\u2013643","journal-title":"Immunity"},{"key":"2037_CR40","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","volume":"20","author":"CM Jackson","year":"2019","unstructured":"Jackson CM, Choi J, Lim M (2019) Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat Immunol 20:1100\u20131109","journal-title":"Nat Immunol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02037-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02037-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:38:02Z","timestamp":1768408682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02037-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02037-w","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed all applicable institutional and\/or national guidelines for the care and use of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}